Previous studies have illustrated that EIF5A2 is highly expressed in ovarian tumor tissues and acts as an oncogenic role in EOC patients [21, 22], but the effect of EIF5A2 in CSCs and specific mechanism in EOC remains largely unclear. Here, EIF5A2 is linked to ovarian neoplasm.